Snowball logo
logo
2196_logo

Shanghai Fosun Pharmaceutical Group Co Ltd

2196 β€’ HK
HK$16.29-HK$0.22Β  (1.33%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
39,005.143,951.541,399.538,589.340,424.361,752
COGS
20,228.323,169.721,716.620,076.520,261.830,793.2
Gross Profit
18,776.820,781.919,682.918,512.920,162.530,958.8
Operating Expenses & Income
Operating Income
6,313.78,296.63,307.53,9892,535.25,123.6
Total Operating Expenses
16,055.817,14516,496.714,523.917,627.325,835.2
R&D Expenses
3,834.54,302.14,367.63,424.53,908.75,250.8
Selling General & Admin Expenses
846.1988.14,374.91,046.71,037.16,800.6
Earnings from Continuing Operations
Interest Expense
(822.5)(963.8)(1,324.8)(1,458.8)(1,232.6)(1,520.4)
Interest Income
1,200.31,154363.6549.8300.5135.9
Income Tax Expense
1,066.4626.9369.5617.2841.71,114.2
Net Income
Net Income
4,728.73,730.82,386.32,602.83,283.35,030.6
Supplemental
EBIT
6,865.25,538.24,589.45,263.22,535.2-
EBITDA
8,699.67,874.17,554.68,083.76,163.27,407.6
In millions of HKD, except % and values per 1 share